199
Views
29
CrossRef citations to date
0
Altmetric
TechnicalNote

Fecal calprotectin: assessment of a rapid test

, , &
Pages 343-347 | Received 29 Apr 2007, Accepted 16 Jul 2007, Published online: 08 Jul 2009

References

  • Dale I., Brandtzaeg P., Fagerhol M. K., Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leuckocytes. Am J Clin Pathol 1985; 84: 24–34
  • Striz I., Trebichavsky I. Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004; 53: 245–53
  • Tibble J., Teahon K., Thjodleifsson B., Røseth A., Sigthorsson G., Bridger S., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506–13
  • Fagerberg U. L., Lööf L., Myrdal U., Hansson L., Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. Pediatr Gastroenterol Nutr 2005; 40: 450–55
  • Kronborg O., Ugstad M., Fuglerud P., Johne B., Hardcastle J., Scholefield J. H., et al. Fecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000; 46: 795–800
  • Røseth A. G., Fagerhol M. K., Aadland E., Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. Scand J Gastroenterol 1992; 27: 793–98
  • Tøn H., Brandsnes Ø., Dale S., Holtlund J., Skuibina E., Schjønsby H., et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000; 292: 41–54
  • Tibble J. A., Sigthorsson G., Bridger S., Fagerhol M. K., Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119: 15–22
  • Røseth A. G., Aadland E., Jahnsen J., Raknerud N. Assessment of disease activity in ulcerative colitis by fecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58: 176–80
  • Bunn S. K., Bisset W. M., Main M. J. C., Gray E. S., Olson S., Golden B. E. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. Pediatr Gastroenterol Nutr 2001; 33: 14–22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.